Northern Trust’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-87,885
| Closed | -$179K | – | 4853 |
|
|
2021
Q3 | $179K | Sell |
87,885
-2,857
| -3% | -$6.65K | ﹤0.01% | 4226 |
|
|
2021
Q2 | $269K | Sell |
90,742
-377,361
| -81% | -$996K | ﹤0.01% | 4008 |
|
|
2021
Q1 | $1.29M | Sell |
468,103
-10,150
| -2% | -$30.6K | ﹤0.01% | 3474 |
|
|
2020
Q4 | $1.16M | Buy |
478,253
+62,289
| +15% | +$150K | ﹤0.01% | 3461 |
|
|
2020
Q3 | $874K | Sell |
415,964
-15,742
| -4% | -$53.1K | ﹤0.01% | 3446 |
|
|
2020
Q2 | $1.63M | Buy |
431,706
+26,922
| +7% | +$80.7K | ﹤0.01% | 3148 |
|
|
2020
Q1 | $766K | Buy |
404,784
+9,324
| +2% | +$24.2K | ﹤0.01% | 3322 |
|
|
2019
Q4 | $827K | Buy |
395,460
+60,076
| +18% | +$115K | ﹤0.01% | 3452 |
|
|
2019
Q3 | $802K | Buy |
335,384
+304,613
| +990% | +$818K | ﹤0.01% | 3447 |
|
|
2019
Q2 | $96K | Buy |
+30,771
| New | +$113K | ﹤0.01% | 3979 |
|
|
2018
Q2 | – | Sell |
-237,053
| Closed | -$2.1M | – | 4342 |
|
|
2018
Q1 | $2.1M | Buy |
237,053
+8,212
| +4% | +$61.5K | ﹤0.01% | 3078 |
|
|
2017
Q4 | $1.66M | Buy |
228,841
+24,281
| +12% | +$152K | ﹤0.01% | 3230 |
|
|
2017
Q3 | $1.41M | Buy |
204,560
+41
| +0% | +$283 | ﹤0.01% | 3350 |
|
|
2017
Q2 | $1.46M | Buy |
+204,519
| New | +$945K | ﹤0.01% | 3327 |
|
Northern Trust's SBBP Position: Q4 2021 in Review
Northern Trust sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 87,885 shares — an estimated $179K sold.
Northern Trust first reported a position in SBBP in Q2 2017 and held it in 14 quarters. The position peaked at $2.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- Northern Trust reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- Northern Trust sold 87,885 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $179K.
- Northern Trust first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 14 quarters.
- Northern Trust's Strongbridge Biopharma plc. position peaked at $2.1M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.